The city of Beverly Hills, a plaintiff in lawsuits against an opioid manufacturer and three distributors, plans to use more than $1 million in settlement funds it will receive for opioid education to reduce dependency.
Earlier this year, two settlements were reached that resolved litigation brought by cities and counties against the pharmaceutical companies McKesson, Cardinal Health and AmerisourceBergen, as well as drug manufacturer Janssen Pharmaceuticals and its parent company Johnson & Johnson. The city of Beverly Hills will receive approximately $1.01 million over 18 years, and the funds must be used for opioid abuse prevention and treatment for people addicted to opioids. The city is not required to pay any attorney fees or litigation costs.
“We are pleased to resolve this case and take a proactive role in ending the devastating epidemic of opioid addiction and abuse,” Mayor Robert Wunderlich said.
For information, visit beverlyhils.org.
This site uses Akismet to reduce spam. Learn how your comment data is processed.